🔥🐔 BizChicken 🐔🔥

Companies Similar to Harrow Health, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Assertio Holdings, Inc.

Assertio Holdings, Inc. logo
Market Cap: Low
Employees: Lowest

INDOCIN, CAMBIA, Zipsor, SPRIX, Otrexup

Assertio Holdings, Inc. is a specialty pharmaceutical company delivering medicines for neurology, hospital, pain, and inflammation, including treatments for arthritis, migraines, and more.

Tags: arthritis, migraine, neurology, pain management, pharmaceutical

Symbol: ASRT

Recent Price: $0.88

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Brendan P. O'Grady

Sector: Healthcare

Employees: 53

Address: 100 South Saunders Road, Lake Forest, IL 60045

Phone: 224 419 7106

Leadership

  • Brendan P O’Grady, Chief Executive Officer of Assertio Holdings
  • Sravan Emany, Chief Financial Officer, Ironwood Pharmaceuticals
  • Heather Mason, Former Senior Executive of Abbott Laboratories
  • Jeffrey Vacirca, CEO and Chairman of the Board of New York Cancer & Blood Specialists
  • Peter D. Staple, Chairman of the Board of Directors
  • Sigurd C. Kirk, Former Executive Vice President, Allergan plc.
  • William T. McKee, Former Chief Financial Officer, Barr Pharmaceuticals

Last updated: 2024-12-31

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. logo
Market Cap: Highest
Employees: Highest

EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb

Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.

Tags: biotechnology, diseases, healthcare, injections, medicines, pharmaceuticals, treatment

Symbol: REGN

Recent Price: $702.59

Industry: Biotechnology

CEO: Dr. Leonard S. Schleifer M.D., Ph.D.

Sector: Healthcare

Employees: 14165

Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707

Phone: 914 847 7000

Leadership

  • Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
  • George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
  • Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
  • Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
  • Leonard Brooks, Senior Vice President, Treasurer
  • John Calabro, Senior Vice President, Internal Audit
  • Christina Chan, Senior Vice President, Corporate Affairs
  • Larry Coury, PhD, Senior Vice President, Associate General Counsel
  • Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
  • Matthew Everett, Senior Vice President, Global Procurement
  • Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
  • Rick Hall, Senior Vice President, Human Resources
  • Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
  • Nouhad Husseini, Senior Vice President, Business Development
  • Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
  • Melissa Lozner, Senior Vice President, Chief Compliance Officer
  • Marion McCourt, Executive Vice President, Commercial
  • Bob McCowan, Senior Vice President, IT and Chief Information Officer
  • Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
  • Richard O’Neal, Senior Vice President, Market Access
  • Sally A. Paull, Executive Vice President, Human Resources
  • Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
  • George Poth, Senior Vice President, Real Estate & Facilities Management
  • Alessandra Ravetti, Senior Vice President, Associate General Counsel
  • Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
  • David Snow, Senior Vice President, Global Head, Dupixent Franchise
  • Mark Volpe, Senior Vice President, Tax
  • Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
  • Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
  • Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
  • Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
  • Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
  • Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
  • Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
  • Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
  • Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
  • Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
  • Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
  • Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
  • Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
  • Christos Kyratsous, PhD, Senior Vice President, Research
  • Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
  • John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
  • Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
  • Lynn Macdonald, PhD, Senior Vice President, Research
  • Lori Morton, PhD, Senior Vice President, Research
  • Andrew Murphy, PhD, Executive Vice President, Research
  • Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
  • William Olson, PhD, Senior Vice President, Therapeutic Proteins
  • Mohammed Shameem, PhD, Senior Vice President, Formulations Development
  • L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
  • Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
  • Neil Stahl, PhD, Executive Vice President, Research and Development
  • Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
  • Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
  • Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
  • Frederick Austin, Senior Vice President, Quality Control, Raheen
  • Christine Childrose, Senior Vice President, Human Resources and HR Operations
  • David Crenshaw, Senior Vice President, Associate General Counsel
  • Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
  • Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
  • Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
  • Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
  • Scott Oberman, Senior Vice President, Supply Chain Operations
  • David Simon, Senior Vice President, IOPS Finance and Business Operations
  • Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
  • Benjamin Yocum, Senior Vice President, Manufacturing Operations
  • James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
  • Bonnie L. Bassler, PhD, Director
  • Michael S. Brown, MD, Director
  • N. Anthony Coles, MD, Chair of the Board
  • Joseph L. Goldstein, MD, Director
  • Kathryn Guarini, PhD, Director
  • Christine A. Poon, Lead Independent Director
  • Arthur F. Ryan, Director
  • Huda Y. Zoghbi, MD, Director
  • Samantha Dickon, Director, Development Program Management
  • Gervasio Batista, Sr. Scientist, Neuroscience
  • James K. Gibson, Senior Regional Director, Immunology/Pulmonary
  • Beth Brause, Director, Field Reimbursement Management
  • Eric Prendergast, Director, Pricing Strategy
  • Ashley Neff, Manager, Digital Communications
  • Shari Loock, Associate Director, Sourcing
  • Jennifer Davidson Hamilton, VP and Head of Precision Medicine
  • Yi Zhang, Director, Health Economics & Outcomes Research
  • Wilson Caldwell III, Director, GCO Vendor & Relationship Management
  • David Stein, Director, Medical Operations
  • Regeneron, Corporate
  • Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
  • Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
  • Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
  • Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
  • Jessie Brown, Manager, Integrative Translational Genetics
  • Gisu Eom, Lead Cloud DevOps Engineer
  • Carmen Kenworthy, Scientist, Velocigene
  • Ralph Hazlewood, Sr. Manager, Research Program Management
  • Brandy Bennett, Sr. Director, R&D Strategy & Operations

Last updated: 2024-12-31

Hims & Hers Health, Inc.

Hims & Hers Health, Inc. logo
Market Cap: High
Employees: Medium

Hims & Hers telehealth platform

Hims & Hers Health, Inc. operates a telehealth platform connecting consumers to healthcare professionals for various health and wellness services, offering prescription and non-prescription products.

Tags: hair care, healthcare, mental health, non-prescription, prescriptions, sexual health, skincare, telehealth, wellness

Symbol: HIMS

Recent Price: $25.27

Industry: Household & Personal Products

CEO: Mr. Andrew Dudum

Sector: Consumer Defensive

Employees: 1046

Address: 2269 Chestnut Street, San Francisco, CA 94123

Phone: 415 851 0195

Last updated: 2024-12-31

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

TNX-103, TNX-102 (levosimendan), TNX-201 (imatinib)

Tenax Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases. The company is involved in developing medications such as TNX-103 and TNX-102 (levosimendan) for pulmonary hypertension and heart failure, and TNX-201 (imatinib) for pulmonary arterial hypertension.

Tags: TNX-102, TNX-103, TNX-201, cardiovascular, pharmaceutical, pulmonary diseases

Symbol: TENX

Recent Price: $6.55

Industry: Biotechnology

CEO: Mr. Christopher T. Giordano

Sector: Healthcare

Employees: 5

Address: ONE Copley Parkway, Morrisville, NC 27560

Phone: 919 855 2100

Last updated: 2024-12-31

TherapeuticsMD, Inc.

TherapeuticsMD, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMVEXXY, BIJUVA, ANNOVERA

Therapeutics MD, Inc. operates as a women's healthcare company in the United States, providing treatments for conditions like dyspareunia and vasomotor symptoms, and offering contraceptive solutions and prenatal vitamins.

Tags: Contraceptives, Dyspareunia Treatment, Prenatal Vitamins, Vasomotor Symptoms, Women's Healthcare

Symbol: TXMD

Recent Price: $1.03

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Marlan D. Walker J.D.

Sector: Healthcare

Employees: 1

Address: 951 Yamato Road, Boca Raton, FL 33431

Phone: 561 961 1900

Leadership

  • Marlan Walker, Chief Executive Officer
  • Joe Ziegler, Principle Financial Officer

Last updated: 2024-12-31

Baxter International Inc.

Baxter International Inc. logo
Market Cap: Highest
Employees: Highest

Healthcare Products

Baxter International Inc. develops and provides a wide range of healthcare products worldwide, including dialysis therapies, intravenous and infusion therapies, medical devices for surgery, and patient monitoring technologies.

Tags: Dialysis, Healthcare, Medical Devices, Patient Monitoring, Pharmaceuticals

Symbol: BAX

Recent Price: $28.63

Industry: Medical - Instruments & Supplies

CEO: Mr. Jose E. Almeida

Sector: Healthcare

Employees: 60000

Address: One Baxter Parkway, Deerfield, IL 60015

Phone: 224 948 2000

Last updated: 2024-12-31

Eli Lilly and Company

Eli Lilly and Company logo
Market Cap: Highest
Employees: Highest

Pharmaceuticals

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide, specializing in treatments for diabetes, cancer, and other conditions.

Tags: Biotechnology, Cancer Treatment, Diabetes, Pharmaceuticals

Symbol: LLY

Recent Price: $773.84

Industry: Drug Manufacturers - General

CEO: Mr. David A. Ricks

Sector: Healthcare

Employees: 43000

Address: Lilly Corporate Center, Indianapolis, IN 46285

Phone: 317 276 2000

Last updated: 2024-12-31

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex

Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.

Tags: gastroenterology, hospital care, oncology, pharmaceutical, prescription products, rheumatology

Symbol: CPIX

Recent Price: $2.42

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. A. J. Kazimi MBA

Sector: Healthcare

Employees: 91

Address: 2525 West End Avenue, Nashville, TN 37203

Phone: 615 255 0068

Last updated: 2024-12-31

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ILUVIEN, YUTIQ, DEXYCU, EYP-1901, YUTIQ50

Eye Point Pharmaceuticals, Inc. develops and commercializes ophthalmic products for treating eye diseases, including innovative treatments like ILUVIEN, YUTIQ, and DEXYCU. Their efforts serve the United States, China, and the United Kingdom, focusing on diseases such as diabetic macular edema and chronic non-infectious uveitis.

Tags: DEXYCU, ILUVIEN, YUTIQ, biotechnology, eye diseases, eye health, micro-insert, ophthalmic, ophthalmology, pharmaceutical, treatment, vision

Symbol: EYPT

Recent Price: $7.02

Industry: Biotechnology

CEO: Dr. Jay S. Duker M.D.

Sector: Healthcare

Employees: 121

Address: 480 Pleasant Street, Watertown, MA 02472

Phone: 617 926 5000

Last updated: 2024-12-31

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. logo
Market Cap: High
Employees: Low

WAKIX

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company that develops and commercializes therapies for patients with rare neurological disorders in the United States, including its product WAKIX for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

Tags: United States, WAKIX, narcolepsy, neurological disorders, pharmaceutical

Symbol: HRMY

Recent Price: $34.06

Industry: Biotechnology

CEO: Dr. Jeffrey M. Dayno M.D.

Sector: Healthcare

Employees: 246

Address: 630 West Germantown Pike, Plymouth Meeting, PA 19462

Phone: 484 539 9800

Leadership

  • Jeffrey M. Dayno, MD, President and Chief Executive Officer
  • Kumar Budur, MD, MS, Chief Medical and Scientific Officer
  • Jeffrey Dierks, MBA, Chief Commercial Officer
  • Sandip Kapadia, CPA, MBA, Chief Financial Officer and Chief Administrative Officer
  • Christian Ulrich, General Counsel and Corporate Secretary
  • Cate McCanless, Corporate Affairs and Public Policy
  • Andrew Serafin, JD, MBA, Chief Strategy Officer
  • Tricia Glover, Chief Compliance Officer
  • Audrey Murphy, Vice President, Human Resources
  • David Bradshaw, Technical Operations
  • Jeffrey S. Aronin, Harmony Founder and Non-Executive Chairman Paragon Chairman and Chief Executive Officer
  • Peter Anastasiou, Chief Executive Officer Capsida Biotherapeutics
  • Juan Sabater, Partner Valor Equity
  • Antonio Gracias, Managing Partner/Chief Investment Officer Valor Equity
  • Gary Sender, Former Chief Financial Officer, Nabriva plc Independent Board Member & Consultant
  • Mark Graf, Private Investor, Former Chief Financial Officer Discover Financial Services
  • Linda Szyper, Former Chief Operating Officer McCann Health
  • Andreas Wicki, PhD, Chief Executive Officer HBM Healthcare Investments (Cayman) Ltd

Last updated: 2024-12-31

Harrow Health, Inc.

Harrow Health, Inc. logo
Market Cap: High
Employees: Low

Imprimis Rx, DEXYCU

Harrow Health, Inc. is an ophthalmic-focused healthcare company owning several pharmaceutical businesses and equity interests in clinical-stage companies, dedicated to innovative treatments in eye health and anesthesia.

Tags: drug development, healthcare, ophthalmic-focused, ophthalmology, pharmaceuticals, therapeutics

Symbol: HROW

Recent Price: $33.38

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Mark L. Baum J.D.

Sector: Healthcare

Employees: 315

Address: 102 Woodmont Boulevard, Nashville, TN 37205

Phone: 615 733 4730

Last updated: 2024-12-31

Henry Schein, Inc.

Henry Schein, Inc. logo
Market Cap: Highest
Employees: Highest

Health care products and services

Henry Schein, Inc. provides health care products and services to dental practitioners, physicians, and other health care clinics worldwide, operating through segments focused on Health Care Distribution and Technology and Value-Added Services.

Tags: dental products, health care, medical products, technology services, value-added services

Symbol: HSIC

Recent Price: $69.17

Industry: Medical - Distribution

CEO: Mr. Stanley M. Bergman

Sector: Healthcare

Employees: 26000

Address: 135 Duryea Road, Melville, NY 11747

Phone: 631 843 5500

Last updated: 2024-12-31

IRIDEX Corporation

IRIDEX Corporation logo
Market Cap: Lowest
Employees: Low

Cyclo G6 laser system, IQ 532, and IQ 577 laser photocoagulation systems

IRIDEX Corporation is an ophthalmic medical technology company offering laser systems and devices for the treatment of sight-threatening eye diseases like glaucoma, diabetic macular edema, and retinal diseases.

Tags: diabetic macular edema, eye diseases, glaucoma treatment, medical lasers, ophthalmic technology, retinal diseases

Symbol: IRIX

Recent Price: $1.74

Industry: Medical - Devices

CEO: Mr. Patrick Mercer

Sector: Healthcare

Employees: 111

Address: 1212 Terra Bella Avenue, Mountain View, CA 94043

Phone: 650 940 4700

Last updated: 2024-12-31

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Nyxol

Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

Tags: biopharmaceutical, clinical trials, ophthalmic, refractive disorders, retinal disorders

Symbol: OCUP

Recent Price: $1.17

Industry: Biotechnology

CEO: Mr. George Magrath M.B.A., M.D., M.S.

Sector: Healthcare

Employees: 14

Address: 37000 Grand River Avenue, Farmington Hills, MI 48335

Phone: 248 681 9815

Last updated: 2024-12-31

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. logo
Market Cap: High
Employees: Medium

Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.

Tags: Crysvita, Dojolvi, Evkeeza, Mepsevii, biopharmaceutical, gene therapy, genetic diseases, rare diseases

Symbol: RARE

Recent Price: $42.27

Industry: Biotechnology

CEO: Dr. Emil D. Kakkis M.D., Ph.D.

Sector: Healthcare

Employees: 1276

Address: 60 Leveroni Court, Novato, CA 94949

Phone: 415 483 8800

Last updated: 2024-12-31

scPharmaceuticals Inc.

scPharmaceuticals Inc. logo
Market Cap: Low
Employees: Low

FUROSCIX

sc Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing pharmaceutical products, with a lead product candidate, FUROSCIX, aimed at treating congestion in heart failure patients using an on-body infusor.

Tags: antibiotics, drug development, healthcare, heart failure, pharmaceuticals

Symbol: SCPH

Recent Price: $3.50

Industry: Biotechnology

CEO: Mr. John H. Tucker

Sector: Healthcare

Employees: 135

Address: 2400 District Avenue, Burlington, MA 01803

Phone: 617 517 0730

Leadership

  • John H. Tucker, President and Chief Executive Officer
  • Rachael Nokes, Chief Financial Officer
  • Mike Hassman, Senior Vice President, Technical Operations
  • John Mohr, Pharm.D., FIDP, Senior Vice President, Clinical Development and Medical Affairs
  • William T. Abraham, MD,
  • Mette Kirstine Agger, Co-Founder & CEO, 7TM Pharma A/S
  • Minnie V. Baylor-Henry, President, B-Henry & Associates
  • Sara Bonstein, CFO, Insmed Incorporated
  • Frederick Hudson, Former Partner in Charge of KPMG’s Largest Healthcare Industry Audit Practice Located in the Mid-Atlantic Region
  • Jack A. Khattar, Founder, President & Chief Executive Officer, Supernus Pharmaceuticals
  • Leonard D. Schaeffer, Founding Chairman & CEO, Wellpoint
  • Klaus Veitinger, MD, PhD, Venture Partner, Orbimed
  • Dan Bensimhon, MD, Medical Director Advanced Heart Failure & Mechanical Circulatory Support Program, Cone Health, Greensboro, NC
  • G. Michael Felker, MD, Chief, Heart Failure Service, Division of Cardiology, Duke University School of Medicine
  • Marv Konstam, MD, Professor of Medicine, Tufts University School of Medicine, Chief Physician Executive of the Cardiovascular Center at Tufts Medical Center
  • W. Frank Peacock, MD, FACEP, FACC, FESC, Professor, Vice Chair of Research, Department of Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital
  • Stuart Russell, MD, Regional Director of Heart Failure Program, Duke University School of Medicine
  • James E. Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, Professor of Medicine and Radiology Tufts University School of Medicine
  • William Weintraub, MD, Director of Outcomes Research, MedStar Heart and Vascular Institute

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

AbbVie Inc.

AbbVie Inc. logo
Market Cap: Highest
Employees: Highest

HUMIRA, SKYRIZI, RINVOQ, IMBRUVICA, VENCLEXTA, MAVYRET, CREON, Synthroid, Linzess/Constella, Lupron

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide, offering a range of therapies including HUMIRA for autoimmune diseases and MAVYRET for HCV infection.

Tags: autoimmune diseases, biotechnology, gastroenterology, healthcare, oncology, pharmaceuticals

Symbol: ABBV

Recent Price: $176.20

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Michael

Sector: Healthcare

Employees: 50000

Address: 1 North Waukegan Road, North Chicago, IL 60064-6400

Phone: 847 932 7900

Last updated: 2024-12-31

Cosmos Health Inc.

Cosmos Health Inc. logo
Market Cap: Lowest
Employees: Low

pharmaceuticals, nutraceuticals, medical devices

Cosmos Health Inc. is a vertically integrated pharmaceutical company offering branded and generic pharmaceuticals, medical devices, and more, serving wholesale distributors and retail pharmacies. Headquartered in Chicago, it has distribution centers in Greece and the UK.

Tags: Healthcare, Medical Devices, Nutraceuticals, Pharmaceuticals, Wholesale Distribution

Symbol: COSM

Recent Price: $0.67

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Grigorios Siokas

Sector: Healthcare

Employees: 123

Address: 141 West Jackson Boulevard, Chicago, IL 60604

Phone: 312 536 3102

Last updated: 2024-12-31

Immix Biopharma, Inc.

Immix Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMX-110, IMX-111, IMX-120

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.

Tags: Biopharmaceuticals, Clinical Trials, Inflammation, Oncology, Tissue-Specific Therapeutics

Symbol: IMMX

Recent Price: $2.36

Industry: Biotechnology

CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.

Sector: Healthcare

Employees: 14

Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064

Phone: 310 651 8041

Last updated: 2024-12-31